Ocuphire Pharma Stock Forecast - Daily Balance Of Power
OCUPDelisted Stock | USD 1.13 0.06 5.04% |
Ocuphire Stock Forecast is based on your current time horizon.
Ocuphire |
Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
(0.67) | (0.76) |
Check Ocuphire Pharma Volatility | Backtest Ocuphire Pharma | Trend Details |
Ocuphire Pharma Trading Date Momentum
On August 23 2023 Ocuphire Pharma was traded for 3.99 at the closing time. The top price for the day was 4.05 and the lowest listed price was 3.93 . The trading volume for the day was 154.8 K. The trading history from August 23, 2023 was a factor to the next trading day price gain. The trading delta at closing time against the next closing price was 0.76% . The trading delta at closing time against the current closing price is 0.25% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Ocuphire Pharma to competition
View Ocuphire Pharma Related Equities
Risk & Return | Correlation |
Ocuphire Pharma Market Strength Events
Market strength indicators help investors to evaluate how Ocuphire Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ocuphire Pharma shares will generate the highest return on investment. By undertsting and applying Ocuphire Pharma stock market strength indicators, traders can identify Ocuphire Pharma entry and exit signals to maximize returns.
Ocuphire Pharma Risk Indicators
The analysis of Ocuphire Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ocuphire Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ocuphire stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 3.18 | |||
Standard Deviation | 4.47 | |||
Variance | 19.94 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Ocuphire Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ocuphire Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against Ocuphire Stock
0.72 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
0.7 | WMT | Walmart Aggressive Push | PairCorr |
0.68 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
0.66 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
0.64 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
The ability to find closely correlated positions to Ocuphire Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ocuphire Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ocuphire Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ocuphire Pharma to buy it.
The correlation of Ocuphire Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ocuphire Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ocuphire Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ocuphire Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Ocuphire Stock
If you are still planning to invest in Ocuphire Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ocuphire Pharma's history and understand the potential risks before investing.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |